ATF

:   activating transcription factor

C/EBP

:   CAAT enhancer‐binding protein

CHOP

:   C/EBP homology protein

HSF1

:   heat shock transcription factor 1

HSP

:   heat shock protein

HSR

:   heat shock response

SSBP1

:   single‐stranded DNA binding protein 1

UPR

:   unfolded protein response

Protein homeostasis or proteostasis within a cell is adjusted mainly at the levels of protein synthesis, folding, and degradation, and its maintenance is essential for cellular functions. Environmental and metabolic stresses constantly induce protein misfolding and challenge proteostasis capacity. To cope with these proteotoxic stresses, cells are equipped with adaptive mechanisms accompanied by changes in gene expression \[[1](#feb412863-bib-0001){ref-type="ref"}\]. Among these, the heat shock response (HSR) is an evolutionarily conserved mechanism that is characterized by the induction of a set of heat shock proteins (HSPs) or chaperones, including HSP110, HSP90, HSP70, HSP40, and HSP27, which assist with protein folding, and some non‐HSP proteins involved in protein degradation \[[2](#feb412863-bib-0002){ref-type="ref"}\]. The HSR is regulated mainly at the transcriptional level by heat shock transcription factor 1 (HSF1) in mammalian cells, and it maintains proteostasis capacity in both the nucleus and cytoplasm \[[3](#feb412863-bib-0003){ref-type="ref"}\].

In contrast, analogous adaptive responses against protein misfolding in the endoplasmic reticulum (ER) and mitochondria are called as unfolded protein response in the ER (UPR^ER^) and mitochondrial UPR (UPR^mt^), respectively \[[4](#feb412863-bib-0004){ref-type="ref"}, [5](#feb412863-bib-0005){ref-type="ref"}\]. The latter response is characterized by the induction of mitochondrial chaperones and proteases, which localize and act in the mitochondria in response to the accumulation of misfolded proteins or an imbalance in mitochondrial and nuclear‐encoded proteins in the mitochondria \[[6](#feb412863-bib-0006){ref-type="ref"}, [7](#feb412863-bib-0007){ref-type="ref"}, [8](#feb412863-bib-0008){ref-type="ref"}\]. This response is regulated by the basic leucine zipper (bZIP) transcription factor ATFS‐1 in *C. elegans* \[[9](#feb412863-bib-0009){ref-type="ref"}\]. ATFS‐1, which is localized to the mitochondrial matrix in normal conditions, accumulates in the nucleus and activates the UPR^mt^ genes in response to mitochondrial proteotoxic stress. In addition, several factors including a mitochondrial transporter, transcription factors, and histone‐modifying enzymes are also involved in the UPR^mt^ \[[10](#feb412863-bib-0010){ref-type="ref"}, [11](#feb412863-bib-0011){ref-type="ref"}\]. In particular, histone demethylases JMJD‐3.1 and JMJD‐1.2 are necessary, and their overexpression is sufficient for the UPR^mt^ \[[12](#feb412863-bib-0012){ref-type="ref"}\]. In mammals, the bZIP transcription factor ATF5 is regulated similarly to ATFS‐1 and activates the UPR^mt^ genes during accumulation of truncated ornithine transcarbamylase (ΔOTC) in the mitochondria \[[13](#feb412863-bib-0013){ref-type="ref"}\]. Another bZIP transcription factor CHOP in complex with C/EBP also activates the UPR^mt^ genes, and its expression is induced via activation of JUN, which is mediated by c‐Jun N‐terminal kinase 2 during accumulation of ΔOTC \[[7](#feb412863-bib-0007){ref-type="ref"}, [14](#feb412863-bib-0014){ref-type="ref"}\].

At first, synthesis of a mammalian homolog of the bacterial GroEL protein was found to be elevated during heat shock and was referred to as HSP58 (thereafter HSP60), whereas that of a mitochondrial member of HSP70 family was increased in cells deprived of glucose and was referred to as glucose regulated protein GRP75 (also known as mtHSP70) \[[15](#feb412863-bib-0015){ref-type="ref"}\]. Mammalian HSP60 and HSP10 genes are linked head‐to‐head and share a bidirectional promoter, which is activated during heat shock \[[16](#feb412863-bib-0016){ref-type="ref"}, [17](#feb412863-bib-0017){ref-type="ref"}\]. However, HSF1 was not thought to be involved in the upregulation of HSP60 and HSP10 during the UPR^mt^, because HSP70 was not upregulated simultaneously \[[6](#feb412863-bib-0006){ref-type="ref"}, [7](#feb412863-bib-0007){ref-type="ref"}, [16](#feb412863-bib-0016){ref-type="ref"}\]. Recently, it was suggested that HSF1 in complex with a coactivator, mitochondrial single‐stranded DNA binding protein 1 (SSBP1), regulates the expression of mitochondrial chaperones, including HSP60, HSP10, and mtHSP70, during heat shock \[[18](#feb412863-bib-0018){ref-type="ref"}\]. Of note, not only HSF1 but also mitochondrial SSBP1 accumulates in the nucleus and binds to the promoters of these genes on heat shock conditions \[[18](#feb412863-bib-0018){ref-type="ref"}\]. Therefore, it should be determined whether HSF1 and SSBP1 play an indispensable role in the UPR^mt^. In this study, we showed that HSF1 is required for expression of nuclear‐encoded mitochondrial chaperones, HSP60, HSP10, and mtHSP70, but not for that of Lon protease, in response to impaired mitochondrial proteostasis, whereas SSBP1 is partially required for the induction. Furthermore, HSF1 promoted the maintenance of mitochondrial function during the UPR^mt^.

Materials and methods {#feb412863-sec-0002}
=====================

Cell cultures and treatments {#feb412863-sec-0003}
----------------------------

Immortalized wild‐type (clone \#10) and HSF1‐null (clone \#4) mouse embryonic fibroblasts (MEF) \[[19](#feb412863-bib-0019){ref-type="ref"}\], HeLa (ATCC CCL‐2) cells, and HEK293 (ATCC CRL‐1573) cells were maintained at 37 °C in 5% CO~2~ in Dulbecco\'s modified Eagle\'s medium containing 10% fetal bovine serum (Sigma‐Aldrich St. Louis, MO, USA). Cells were treated with mitochondria‐specific stress reagents, 10 μ[m]{.smallcaps} gamitrinib‐triphenylphosphonium (GTPP) (a kind gift from D. C. Altieri), 5 μ[m]{.smallcaps} synthetic triterpenoid 2‐cyano‐3, 12‐dioxooleana‐1, 9(11)‐dien‐28‐oic acid (CDDO) (Cayman Chemicals, Ann Arbor, MI, USA), and 20 μ[m]{.smallcaps} rotenone (Sigma‐Aldrich, St. Louis, MO, USA) for 6 h.

Assessment of mRNA {#feb412863-sec-0004}
------------------

Total RNA was isolated from cells using TRIzol (Ambion, Carlsband, CA, USA). First‐strand cDNA was synthesized using PrimeScript II Reverse Transcriptase and oligo‐dT primer in accordance with the manufacturer\'s instructions (TAKARA, Kusatsu, Japan). Real‐time quantitative PCR (qPCR) was performed using StepOnePlus (Applied Biosystems, Foster City, CA, USA) with the Power SYBR Green PCR Master Mix (Applied Biosystems) using primers for mouse HSP60 (HSPD1), HSP10 (HSPE1), mtHSP70 (HSPA9), Lon, and HSP70 (HSPA1A and HSPA1B) (Table [S1](#feb412863-sup-0001){ref-type="supplementary-material"}). Relative quantities of mRNAs were normalized against GAPDH or RPLPO (large ribosomal protein) mRNA levels. All reactions were performed in triplicate with samples derived from three experiments.

RNA interference {#feb412863-sec-0005}
----------------

To generate adenovirus vectors expressing short hairpin RNAs against mouse HSF1, SSBP1 and TRAP1, oligonucleotides containing each target sequence (Table [S2](#feb412863-sup-0001){ref-type="supplementary-material"}) were annealed and inserted into pCR2.1‐hU6 at the BamHI/HindIII sites, and then, XhoI/HindIII fragments containing hU6‐shRNA were inserted into a pShuttle‐CMV vector (Stratagene) \[[20](#feb412863-bib-0020){ref-type="ref"}\]. To knock down HSF1, SSBP1, or TRAP1, MEF cells were infected with Ad‐sh‐mHSF1‐KD, Ad‐sh‐mSSBP1‐KD, or Ad‐sh‐mTRAP1‐KD (1 × 10^8^ pfu·mL^−1^) for 2 h and maintained in normal medium for 70 h. As a control, the cells were infected with an adenovirus vector expressing scrambled RNA (Ad‐sh‐SCR).

Western blotting {#feb412863-sec-0006}
----------------

Cells pellets were lysed with NP‐40 buffer (150 m[m]{.smallcaps} NaCl, 1.0% Nonidet P‐40, 50 m[m]{.smallcaps} Tris/HCl, pH 8.0) containing protease inhibitors (1 m[m]{.smallcaps} phenylmethylsulfonyl fluoride, 1 μg·mL^−1^ leupeptin, and 1 μg·mL^−1^ pepstatin) on ice for 10 min. After centrifugation at 16 000 ***g*** for 10 min, supernatants were subjected to SDS/PAGE. For HSP10 blot, a Real Gel Plate with 10‐20% polyacrylamide gel (MDG‐296; BIO CRAFT, Tokyo, Japan) was used. After proteins were transferred onto nitrocellulose or PVDF (SSBP1 blot) membranes, the membranes were blocked in PBS/5% milk at a room temperature for 1 h and then were immunoblotted using rabbit antibodies against HSF1 (anti‐mHSF1j, Millipore ABE1044; dilution, 1 : 1000) \[[21](#feb412863-bib-0021){ref-type="ref"}\], TRAP1 (anti‐mTRAP1a; dilution, 1 : 1000) (this study) HSP60 (anti‐HSP60‐1; 1 : 2000) \[[22](#feb412863-bib-0022){ref-type="ref"}\], HSP10 (Santa Cruz, CA, USA sc‐20958; 1 : 1000), mtHSP70 (or GRP75) (Santa Cruz sc‐13967; 1 : 1000), and SSBP1 (anti‐mSSBP1x; dilution, 1 : 1000) (this study), and mouse antibody for HSP70 (Santa Cruz W27; 1 : 1000) and β‐actin (AC‐15; Sigma, St. Louis, MO, USA) diluted in PBS/2% milk at a room temperature for 1 h or at 4 °C overnight. The membranes was washed three times with PBS for 5 min and incubated at room temperature for 1 h with secondary antibodies: peroxidase‐conjugated goat anti‐rabbit or anti‐mouse IgG. After washing with PBS/0.1% Tween‐20 three times, chemiluminescent signals from ECL detection reagents (GE Healthcare, Buckinghamshire, UK) were captured on X‐ray film (Super RX; Fujifilm, Tokyo, Japan). Intensity of the bands was quantified using NIH [imagej]{.smallcaps} (NIH, Washington, DC, USA). We generated rabbit antisera against mouse TRAP1 (anti‐mTRAP1a) and SSBP1 (anti‐mSSBP1x) by immunizing rabbits using TiterMax Gold adjuvant (CytRx, Los Angeles, CA, USA) with bacterially expressed recombinant GST‐mTRAP1 (full‐length protein) and GST‐mSSBP1 (full‐length protein), respectively.

Cross‐linking {#feb412863-sec-0007}
-------------

Mouse embryonic fibroblasts cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, or 20 μ[m]{.smallcaps} rotenone for 6 h, or heat shock at 42 °C for 30 min. Whole‐cell extracts were prepared in buffer C (0.42 [m]{.smallcaps} NaCl, 20 m[m]{.smallcaps} HEPES/NaOH, pH 7.9, 25% glycerol, 1.5 m[m]{.smallcaps} MgCl~2~, 0.2 m[m]{.smallcaps} EDTA) containing protease inhibitors \[[21](#feb412863-bib-0021){ref-type="ref"}\]. Aliquots containing 40 μg protein were mixed with a 0.05 volume of 100 m[m]{.smallcaps} disuccinimidyl glutarate (DSG) (final concentration of 5 m[m]{.smallcaps}) at room temperature for 30 min and were subjected to western blotting using HSF1 antibody (anti‐mHSF1j).

Immunofluorescence {#feb412863-sec-0008}
------------------

HeLa cells were grown on coated glass coverslips in 35 mm culture dishes for 16 h at 37 °C in 5% CO~2~. Cells were fixed with 100% methanol at −20 °C for 15 min and then washed three times with PBS for 5 min each. Subsequently, they were permeabilized and blocked with PBS/0.1% Triton X‐100/5% goat serum at room temperature for 1 h. After washing with PBS once, the coverslips were incubated with rat monoclonal IgG for HSF1 (10H8, ab61382; Abcam, Cambridge, UK) (1 : 200 dilution) at 4 °C overnight and washed three times with PBS. They were then incubated with FITC‐conjugated goat anti‐rabbit IgG (Cappel) (1 : 200 dilution in PBS/2% milk) or Alexa Flour 546‐conjugated goat anti rat IgG (Molecular Probes, Eugene, OR, USA) (1 : 200 dilution) at room temperature for 1 h. Coverslips were washed three times with PBS for 5 min each and then mounted in a VECTASHIELD with 4′,6‐diamino‐2‐phenylindole (DAPI) mounting medium (Vector Laboratories, Burlingame, CA, USA). High‐resolution (×63 objective magnification) confocal images were taken using LSM510 META confocal microscope (Carl Zeiss, Jena, Germany) and were quantified by using Zen lite software (Carl Zeiss). HSF1 fluorescence signals in a total cell and a nucleus were estimated by measuring the average intensities of pixels by manually tracing cellular periphery and the region stained with DAPI, respectively. Percentage of HSF1 fluorescence signal localized in the nucleus was calculated by normalizing the nuclear signal intensity to total fluorescence intensity from the cell.

Chromatin immunoprecipitation analysis {#feb412863-sec-0009}
--------------------------------------

ChIP experiments were performed using a kit in accordance with the manufacturer\'s instructions (EMD Millipore, Burlington, MA, USA). The antibody used for ChIP assays was anti‐mHSF1j. Real‐time qPCR of ChIP‐enriched DNAs in *HSP60*, *mtHSP70*, *HSP70* (*HSPA1A*), and its intergenic region was performed using the primers listed in Table [S3](#feb412863-sup-0001){ref-type="supplementary-material"}. Percentage input was determined by comparing the cycle threshold value of each sample to a standard curve generated from a 5‐point serial dilution of genomic input and compensated by values obtained using normal IgG. IgG‐negative control immunoprecipitations for all sites yielded \< 0.05% input. All reactions were performed in triplicate with samples derived from three experiments.

Measurement of mitochondrial membrane potential and oxygen consumption {#feb412863-sec-0010}
----------------------------------------------------------------------

Mouse embryonic fibroblast cells, which were infected with Ad‐sh‐mHSF1‐KD or Ad‐sh‐SCR, were seeded into plastic 96 well plates at a density of 5 × 10^4^ cells/well and grown for 16 h. After treatment with each inhibitor for 3 h, the cells were stained with MitoTracker Red CMXRos (Molecular Probes) for 30 min. The wells were washed twice with PBS to remove excess fluorescent dye, and fluorescence signals were measured at 540 nm/615 nm (excitation/emission) using an ARVO X4 multilabel plate reader (PerkinElmer, Inc., Waltham, MA, USA). Alternatively, cells infected with Ad‐sh‐mHSF1‐KD or Ad‐sh‐SCR were grown on glass coverslips in 35 mm culture dishes for 16 h, treated as described above, and were fixed with 100% methanol at −20 °C for 15 min. Coverslips were washed three times with PBS for 5 min each and then mounted in a VECTASHIELD with DAPI mounting medium (Vector Laboratories). High‐resolution (×63 objective magnification) confocal images were taken using LSM510 META confocal microscope (Carl Zeiss).

Oxygen consumption was examined by using MitoXpress Xtra Oxygen Consumption Assay (Agilent, Chicopee, MA, USA) in accordance with the manufacturer\'s instructions. MEF cells were treated as described above in plastic 96 well plates and maintained at 37 °C on a thermoregulator. The cells were loaded with a reagent containing the oxygen‐sensitive MitoXpress Xtra fluorescent probe and treated with or without 500 n[m]{.smallcaps} FCCP (Cayman Chemical) or 5 μ[m]{.smallcaps} antimycin A (Abcam), and were covered by mineral oil. Each sample well was then measured at 340 nm/642 nm (excitation/emission) repetitively every 5 min over 120 min using an ARVO X4 multilabel plate reader (PerkinElmer, Inc.), by taking TR‐F intensity readings at delay time of 30 and 70 μs and gate time 100 μs. Measured TR‐F intensity signals (counts·s^−1^) were converted into lifetime signals (μs). Relative oxygen consumption rate (OCR) was estimated as a value of MitoXpress Xtra fluorescence lifetime signal per hour per mg of protein (μs·h^−1^·mg^−1^).

Statistical analysis {#feb412863-sec-0011}
--------------------

Data were analyzed using Student\'s *t*‐test for comparisons between two groups. Multiple‐group differences were assessed by one‐way ANOVA test, followed by the Tukey *post hoc* test ([jmp pro]{.smallcaps} 14 software; SAS Institute Inc., Cary, NC, USA). Asterisks in figures indicate that differences were significant (*P* \< 0.01 or 0.05). Error bars represent the standard deviations for more than three independent experiments.

Results {#feb412863-sec-0012}
=======

HSF1 is required for activation of mitochondrial chaperone genes {#feb412863-sec-0013}
----------------------------------------------------------------

To examine the roles of HSF1 in the UPR^mt^, we treated immortalized MEF cells with three reagents that target mitochondrial proteins and impair mitochondrial proteostasis. GTPP inhibits the matrix HSP90 chaperone TRAP1 \[[23](#feb412863-bib-0023){ref-type="ref"}, [24](#feb412863-bib-0024){ref-type="ref"}\], and CDDO inhibits the matrix protease Lon \[[25](#feb412863-bib-0025){ref-type="ref"}\]. Rotenone is an inhibitor of the electron transfer complex 1 (ETC1) and increases production of reactive oxygen species (ROS). Protein levels of HSP60 and HSP10 were increased by treatment with GTPP or CDDO at concentrations of 5--20 μ[m]{.smallcaps}, but were not by treatment with rotenone (Fig. [1A](#feb412863-fig-0001){ref-type="fig"}). In contrast, mtHSP70 protein levels were increased by treatment with 10--50 μ[m]{.smallcaps} rotenone and were slightly increased by treatment with GTPP or CDDO. HSP60 mRNA levels were also increased by treatment with GTPP or CDDO, and mtHSP70 mRNA levels were increased by treatment with rotenone (Fig. [1B](#feb412863-fig-0001){ref-type="fig"}). Thus, the treatment of MEF cells with these reagents induced at least some mitochondrial HSPs in a dose‐dependent manner, as reported previously \[[26](#feb412863-bib-0026){ref-type="ref"}, [27](#feb412863-bib-0027){ref-type="ref"}\]. We then treated wild‐type and HSF1‐null MEF cells with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, or 20 μ[m]{.smallcaps} rotenone for 6 h and found that HSP60, HSP10, and mtHSP70 mRNA levels were increased by 1.2‐ to 2.0‐fold in wild‐type cells treated with GTPP and CDDO, and only mtHSP70 mRNA levels were significantly increased in cells treated with rotenone (Fig. [1C](#feb412863-fig-0001){ref-type="fig"}). Remarkably, mRNA levels of these genes were not induced in HSF1‐null cells at all. mRNA levels of HSP70 were simultaneously increased by 10‐ to 45‐fold in wild‐type cells in a HSF1‐dependent manner, suggesting that cytoplasmic proteostasis was also impaired in these conditions (Fig. [1C](#feb412863-fig-0001){ref-type="fig"}) \[[28](#feb412863-bib-0028){ref-type="ref"}\]. In marked contrast, expression of mitochondrial protease Lon mRNA was induced in both wild‐type and HSF1‐null cells during the treatment (Fig. [1D](#feb412863-fig-0001){ref-type="fig"}). To exclude nonspecific effects of GTPP, we knocked down TRAP1 and confirmed that both HSP60 and HSP70 protein levels were increased in TRAP1‐knockdown cells (Fig. [1E](#feb412863-fig-0001){ref-type="fig"}) \[[27](#feb412863-bib-0027){ref-type="ref"}, [29](#feb412863-bib-0029){ref-type="ref"}\]. HSP60, HSP10, and HSP70 mRNA levels were also increased by about 1.5‐fold (Fig. [1F](#feb412863-fig-0001){ref-type="fig"}). However, they were not increased at all in TRAP1‐knockdown cells deficient in HSF1. These results demonstrated that HSF1 is required for activation of mitochondrial chaperone genes, but not for that of *Lon* protease gene, during the UPR^mt^ in mouse cells, when mitochondrial proteostasis is impaired by targeting a mitochondrial chaperone or protease, or an ETC component.

![HSF1 is required for the activation of mitochondrial chaperone genes. (A) Induction of mitochondrial chaperones during treatment with reagents that target mitochondrial proteins. MEF cells were treated with GTPP, CDDO, or rotenone at the indicated concentrations for 6 h. Cell extracts were prepared using NP‐40 lysis buffer and were subjected to western blotting (upper). Intensity of HSP bands in representative blots was quantified using NIH [imagej]{.smallcaps} and normalized to the intensity of each actin loading control. Fold changes during treatments are shown (lower). (B) Induction of HSP60 and mtHSP70 mRNAs during treatment with reagents that target mitochondrial proteins. mRNA levels were quantified by RT‐qPCR (*n* = 3). Mean ± SD is shown. Asterisks indicate *P* \< 0.01 or 0.05 by one‐way ANOVA, compared with each mRNA level in untreated cells. (C) HSF1 is required for the induction of mitochondrial HSP mRNAs in cells treated with the indicated reagents. Wild‐type (HSF1+/+) and HSF1‐null (HSF1−/−) MEF cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, and 20 μ[m]{.smallcaps} rotenone for 6 h. mRNA levels of HSP60, HSP10, mtHSP70, and HSP70 were quantified by RT‐qPCR (*n* = 3). Mean ± SD is shown. Asterisks indicate *P* \< 0.01 or 0.05 by Student\'s *t*‐test. (D) HSF1 is not required for the induction of Lon mRNAs in cells treated with the indicated reagents. Cells were treated as is shown in B. mRNA levels of Lon were quantified by RT‐qPCR (*n* = 3). Mean ± SD is shown. Asterisks indicate *P* \< 0.01 or 0.05 by Student\'s *t*‐test. (E) HSP60 is induced by TRAP1 knockdown. MEF cells were infected with an adenovirus expressing scrambled RNA (SCR) or shRNA for TRAP1 (TRAP1‐KD) at the indicated concentration (0.5 to 2 × 10^8^ PFU·mL^−1^) for 2 h, maintained with normal medium for 70 h. Cell extracts were prepared and subjected to western blotting. (F) HSF1 is required for the induction of HSP60 and HSP10 mRNAs in TRAP1‐knockdown cells. Wild‐type (HSF1+/+) and HSF1‐null (HSF1−/−) MEF cells were infected with each adenovirus (1 × 10^8^ PFU·mL^−1^) as described in (E). mRNA levels of HSP60, HSP10, and HSP70 were quantified by RT‐qPCR (*n* = 3). Mean ± SD is shown (right). Asterisks indicate *P* \< 0.01 by Student\'s *t*‐test. Cell extracts were prepared and subjected to western blotting (left).](FEB4-10-1135-g001){#feb412863-fig-0001}

Different requirement of SSBP1 for activation of the mitochondrial chaperone genes {#feb412863-sec-0014}
----------------------------------------------------------------------------------

We then investigated the effects of SSBP1 on the activation of UPR^mt^ genes in response to impaired mitochondrial proteostasis. MEF cells were infected for 72 h with an adenovirus expressing short hairpin RNA for SSBP1 or HSF1, or scrambled RNA (SCR) as a control, and protein level of SSBP1 or HSF1 was transiently reduced (Fig. [2A](#feb412863-fig-0002){ref-type="fig"}). We confirmed that the expression of HSP60, HSP10, and mtHSP70 mRNAs as well as HSP70 mRNA was hardly increased in HSF1‐knockdown cells during treatment with GTPP, CDDO, or rotenone (Fig. [2B--D](#feb412863-fig-0002){ref-type="fig"}, black bars). In SSBP1‐knockdown cells, the expression of HSP70 mRNA was partially increased during the same treatment (Fig. [2B--D](#feb412863-fig-0002){ref-type="fig"}, gray bars), like during treatment with heat shock \[[18](#feb412863-bib-0018){ref-type="ref"}\]. In marked contrast, HSP60 mRNA expression was not increased at all in SSBP1‐knockdown cells during treatment with GTPP or CDDO. Similarly, HSP10 mRNA expression was less increased in SSBP1‐knockdown cells during GTPP and CDDO treatment than scrambled RNA‐treated cells (Fig. [2B,C](#feb412863-fig-0002){ref-type="fig"}, gray bars). On the other hand, mtHSP70 mRNA expression was fully increased in SSBP1‐knockdown cells during CDDO treatment, whereas it was less increased in the same cells treated with GTPP or rotenone (Fig. [2B--D](#feb412863-fig-0002){ref-type="fig"}, gray bars). These results suggested different requirements of SSBP1 on the activation of mitochondrial chaperone genes during the UPR^mt^.

![Different requirements of SSBP1 for the activation of mitochondrial chaperone genes. (A) Knockdown of HSF1 or SSBP1. MEF cells were infected with an adenovirus expressing scrambled RNA (SCR) or shRNA for SSBP1 (SSBP1‐KD) or HSF1 (HSF1‐KD) for 2 h, maintained with normal medium for 70 h. Cell extracts were prepared and subjected to western blotting. (B--D) Activation of the mitochondrial chaperone genes in SSBP1‐ or HSF1‐knockdown cells. SSBP1 or HSF1 was knocked down as described in (A). The cells were treated with 10 μ[m]{.smallcaps} GTPP (B), 5 μ[m]{.smallcaps} CDDO (C), and 20 μ[m]{.smallcaps} rotenone (D) for 6 h. mRNA levels of HSP60, HSP10, mtHSP70, and HSP70 were quantified by RT‐qPCR (*n* = 3). Mean ± SD is shown. Asterisks indicate *P* \< 0.01 or 0.05 by Student\'s *t*‐test (ns, not significant).](FEB4-10-1135-g002){#feb412863-fig-0002}

Nuclear translocation, trimer formation, and phosphorylation of HSF1 {#feb412863-sec-0015}
--------------------------------------------------------------------

We investigated whether HSF1 is activated directly or indirectly during treatment with GTPP, CDDO, or rotenone. HSF1 activation involves its nuclear translocation, trimer formation, and phosphorylation of a specific residue \[[30](#feb412863-bib-0030){ref-type="ref"}, [31](#feb412863-bib-0031){ref-type="ref"}\]. First, we performed immunofluorescence analysis of HeLa cells using confocal microscopy because HSF1 localization was intensively studied in the cells \[[18](#feb412863-bib-0018){ref-type="ref"}\]. We found that HSF1 localizes to both the cytoplasm and nucleus in unstressed cells and slightly accumulates in the nucleus during treatment with GTPP, CDDO, or rotenone (Fig. [3A,B](#feb412863-fig-0003){ref-type="fig"}). Nuclear foci termed HSF1 granules were detected in cells treated with heat shock but not in cells treated with these reagents. Second, we examined the oligomeric form of HSF1 using DSG cross‐linking experiments. Monomeric HSF1 shifted to a trimeric form during treatment of MEF cells with heat shock and was partly shifted to a trimeric form during treatment with GTPP, CDDO, or rotenone (Fig. [3C](#feb412863-fig-0003){ref-type="fig"}). Third, we studied HSF1‐Ser326 phosphorylation, which is an active mark of HSF1 transcriptional activity \[[32](#feb412863-bib-0032){ref-type="ref"}\]. Because a specific antibody for human HSF1‐Ser326, but not for mouse HSF1‐Ser326, is available, we replaced endogenous HSF1 with human HSF1 in MEF cells. It was revealed that hHSF1‐Ser326 was phosphorylated at lower levels in cells treated with GTPP, CDDO, or rotenone than in cells treated with heat shock at 42 °C 90 min (Fig. [3D](#feb412863-fig-0003){ref-type="fig"}). Hyperphosphorylation of HSF1, which is detected as retarded bands on a gel, is often correlated with the activation of HSF1, but was not evident in the same cells. These results suggested that HSF1 is modestly activated in response to impaired mitochondrial proteostasis.

![HSF1 is moderately activated in response to impaired mitochondrial proteostasis. (A) Nuclear translocation of HSF1 in response to impaired mitochondrial proteostasis. HeLa cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, or 20 μ[m]{.smallcaps} rotenone for 6 h. Some cells were also treated with heat shock at 42 °C for 30 min. The cells were costained with an antibody for HSF1 and the nuclear marker DAPI, and fluorescence images were merged (Merge). Bars, 20 μm. (B) Quantitative estimation of HSF1 signals in the nucleus. Fluorescence signals in the nucleus and total fluorescence signals from the cell were estimated (*n* = 20), and percentages of HSF1 localized in nucleus are shown. Mean ± SD is shown. Asterisks indicate *P* \< 0.01 by one‐way ANOVA, compared with the percentage in control cells. (C) Trimer formation of HSF1. MEF cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, or 20 μ[m]{.smallcaps} rotenone for 6 h, or heat shock at 42 °C for 30 min. Whole‐cell extracts were prepared, and aliquots containing 40 μg protein were mixed with a cross‐linking reagent DSG at a final concentration of 5 m[m]{.smallcaps} at room temperature for 30 min and were subjected to western blotting using HSF1 antibody. Positions of HSF1 monomer, dimer, and trimer are indicated on the right. (D) Phosphorylation of HSF1‐Ser326. HSF1‐null (HSF1−/−) cells were infected with adenovirus expressing HA‐tagged human HSF1 (1 × 10^8^ pfu·mL^−1^) for 2 h and maintained with normal medium for 46 h. The cells were treated with GTPP, CDDO, or rotenone at the indicated concentrations for 6 h (left), or treated with 20 μ[m]{.smallcaps} rotenone for 6 h or heat shock (HS) at 42 °C for 30, 60, or 90 min (right). Cell extracts were prepared and subjected to western blotting using HSF1‐phospho‐S326 (S326P), HA, or β‐actin antibody. An asterisk indicates nonspecific bands.](FEB4-10-1135-g003){#feb412863-fig-0003}

HSF1 occupancy in HSP60/HSP10 promoter is remarkably high {#feb412863-sec-0016}
---------------------------------------------------------

It was assumed that HSF1 mildly occupies mitochondrial chaperone gene promoters *in vivo* in impaired mitochondrial proteostasis conditions, because it is activated only modestly. As shown previously, HSF1 heavily bound to *HSP60/HSP10* promoter as well as *HSP70* (*HSPA1A*) promoter, and a little to *mtHSP70* promoter during heat shock at 42 °C for 30 min (Fig. [4A,B](#feb412863-fig-0004){ref-type="fig"}). In contrast, HSF1 moderately bound to *HSP70* promoter in cells treated with GTPP and CDDO and bound to it at a lower level in cells treated with rotenone. HSF1 constitutively bound to *mtHSP70* promoter to some extent, and its binding was induced moderately in cells treated with rotenone and was little induced in cells treated with GTPP and CDDO. HSF1 also constitutively bound to *HSP60/HSP10* promoter to some extent, and the levels of HSF1 binding were little induced in cells treated with rotenone. Contrary to our expectation, the levels of HSF1 binding were heavily induced in cells treated with GTPP and CDDO, like in cells treated with heat shock (Fig. [4A,B](#feb412863-fig-0004){ref-type="fig"}). Furthermore, we confirmed that levels of HSF1 binding to *HSP60/HSP10* promoter were markedly induced in TRAP1‐knockdown cells (Fig. [4C](#feb412863-fig-0004){ref-type="fig"}). These results indicated that HSF1 occupancy on the mitochondrial chaperone gene promoters is induced at different levels. HSF1 occupancy in *HSP60/HSP10* promoter was remarkably high during the treatment with GTPP and CDDO, whereas that in *mtHSP70* or *HSP70* promoter was moderate.

![HSF1 occupancy on the mitochondrial chaperone gene promoters is induced at different levels. (A) Schematic representation of mouse *HSP60/HSP10*, *mtHSP70*, and *HSP70 (HSPA1A)* loci. Nucleotide sequences of each HSE and consensus nGAAn sequences are shown. Amplified promoter regions by qPCR using each specific primer pairs are indicated. (B) HSF1 occupancy is induced in response to impaired mitochondrial proteostasis. MEF cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, 20 μ[m]{.smallcaps} rotenone for 6 h, or heat shock at 42 °C for 30 min. ChIP‐qPCR performed on each promoter region using HSF1 antibody (*n* = 3). Mean ± SD is shown. Asterisks indicate *P* \< 0.01 or 0.05 by one‐way ANOVA, compared between two groups. (C) TRAP1 knockdown enhances HSF1 occupancy on *HSP60/HSP10* promoter. MEF cells were infected for 72 h with Ad‐sh‐mTRAP1‐KD, and ChIP‐qPCR analyses were performed using HSF1 antibody. Mean ± SD is shown (*n* = 3) (left). Asterisks indicate *P* \< 0.01 by Student\'s *t*‐test. Cell extracts were prepared and subjected to western blotting (right).](FEB4-10-1135-g004){#feb412863-fig-0004}

HSF1 promotes the maintenance of mitochondrial function {#feb412863-sec-0017}
-------------------------------------------------------

To test whether HSF1‐mediated expression of UPR^mt^ genes is related with mitochondrial function, we first examined mitochondrial membrane potential using a fluorescent probe MitoTracker Red. The intensity of MitoTracker fluorescence was not affected when MEF cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, or 20 μ[m]{.smallcaps} rotenone for 3 h (Fig. [5A](#feb412863-fig-0005){ref-type="fig"}). However, it was significantly reduced in HSF1‐knockdown cells treated with GTPP or rotenone, but not in those cells treated with CDDO. We next examined the basal (−FCCP) and maximal (+FCCP) oxygen consumption in the same cells (Fig. [5B](#feb412863-fig-0005){ref-type="fig"}). The relative oxygen consumption rate (OCR) was not significantly reduced by HSF1 knockdown, but was reduced in cells treated with GTPP, CDDO, or rotenone for 3 h. Remarkably, the levels of basal and maximal respiration in the presence of GTPP, CDDO, or rotenone were more reduced in HSF1‐knockdown cells than those in scrambled RNA‐treated cells. These results suggested that HSF1 promotes the maintenance of mitochondrial function in response to impaired mitochondrial proteostasis.

![HSF1 is involved in the maintenance of mitochondrial function. (A) HSF1 supports the maintenance of mitochondrial membrane potential. Control (SCR) and HSF1‐knockdown (HSF1‐KD) MEF cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, or 20 μ[m]{.smallcaps} rotenone for 3 h or treated with 10 μ[m]{.smallcaps} FCCP for 20 min as a control. The cells were stained with MitoTracker Red CMXRos (upper), and MitoTracker fluorescent signals were measured (arbitrary fluorescence unit) (lower). Mean ± SD is shown (*n* = 3). Asterisks indicate *P* \< 0.05 by Student\'s *t*‐test. Bars, 20 μm. (B) HSF1 supports the maintenance of oxygen consumption. Control (SCR) and HSF1‐knockdown (HSF1‐KD) MEF cells were treated with 10 μ[m]{.smallcaps} GTPP, 5 μ[m]{.smallcaps} CDDO, or 20 μ[m]{.smallcaps} rotenone for 3 h and mixed with MitoXpress Xtra reagent containing an oxygen‐sensitive fluorescence probe. Fluorescent signals were measured in the presence (lower) or absence (upper) of 500 n[m]{.smallcaps} FCCP. Fluorescent signals in the presence of 5 μ[m]{.smallcaps} antimycin A were measured as a control. Relative oxygen consumption rate (OCR) was estimated as a value of MitoXpress Xtra fluorescence lifetime signal per hour per mg of protein (μs·h^−1^·mg^−1^). Mean ± SD is shown (*n* = 3). Asterisks indicate *P* \< 0.01 or 0.05 by Student\'s *t*‐test.](FEB4-10-1135-g005){#feb412863-fig-0005}

Discussion {#feb412863-sec-0018}
==========

Mitochondria are the central hub of metabolic and signaling processes including ATP production and apoptotic cell death \[[33](#feb412863-bib-0033){ref-type="ref"}, [34](#feb412863-bib-0034){ref-type="ref"}\], and declines in mitochondrial function are associated with aging and disorders, such as neurodegenerative diseases and cancer \[[35](#feb412863-bib-0035){ref-type="ref"}, [36](#feb412863-bib-0036){ref-type="ref"}\]. Cells must adapt to a large variety of mitochondrial dysfunctions by changing nuclear‐encoded mitochondrial gene expression. Among these homeostatic mechanisms, the UPR^mt^ is an adaptive response to accumulation of misfolded proteins in mitochondria. ATF5 and CHOP have been shown to be required for the activation of UPR^mt^ genes during accumulation of ΔOTC in human HEK293 and monkey COS‐7 cells, respectively \[[7](#feb412863-bib-0007){ref-type="ref"}, [13](#feb412863-bib-0013){ref-type="ref"}\]. In this study, we used immortalized MEF cells for analysis of the UPR^mt^, and mechanisms of the UPR^mt^ were analyzed during treatment with GTPP, CDDO, or rotenone \[[26](#feb412863-bib-0026){ref-type="ref"}, [27](#feb412863-bib-0027){ref-type="ref"}, [37](#feb412863-bib-0037){ref-type="ref"}\], which induces the expression of HSP60, HSP10, mtHSP70, or Lon as well as cytoplasmic HSP70. We showed that both disruption of *HSF1* gene and transient HSF1 knockdown abolished the upregulation of mitochondrial chaperone genes, but not for that of protease *Lon*, during the UPR^mt^ (Figs [1](#feb412863-fig-0001){ref-type="fig"} and [2](#feb412863-fig-0002){ref-type="fig"}). In contrast, SSBP1 is required for the upregulation of only *HSP60*. Even in unstressed conditions, HSF1 constitutively occupied *HSP60/HSP10* and *mtHSP70* promoters (Fig. [4](#feb412863-fig-0004){ref-type="fig"}). Furthermore, a very small part of HSF1 accumulated in the nucleus, shifted to a trimeric form, and was phosphorylated at Ser326, suggesting that HSF1 was activated directly or indirectly in response to impaired mitochondrial proteostasis (Fig. [3](#feb412863-fig-0003){ref-type="fig"}). Although treatment with the inhibitors may also cause proteostasis impairment in the cytoplasm, our observation indicated that HSF1 is required for activation of mitochondrial chaperone genes during the UPR^mt^.

HSF1 has been shown to plays roles in the maintenance of mitochondrial function through different pathways. HSF1 deficiency causes reduced constitutive expression of cytoplasmic HSPs including HSP25, which is associated with a decrease in cellular GSH/GSSG ratio and an increase in mitochondrial oxidative stress in the heart, kidney, and oocytes \[[38](#feb412863-bib-0038){ref-type="ref"}, [39](#feb412863-bib-0039){ref-type="ref"}, [40](#feb412863-bib-0040){ref-type="ref"}, [41](#feb412863-bib-0041){ref-type="ref"}\]. Induction of HSPs, including HSP60 and HSP10, by HSF1 and SSBP1 promotes the maintenance of mitochondrial membrane potential in proteotoxic stress conditions, which are caused by heat shock or proteasome inhibition \[[18](#feb412863-bib-0018){ref-type="ref"}\]. Furthermore, activation of HSF1 is associated with increased mitochondrial function by enhancing the expression of PGC1α, which is a central regulator of mitochondrial biogenesis and function \[[42](#feb412863-bib-0042){ref-type="ref"}\]. Consistently, mitochondrial function such as mitochondrial membrane potential is suggested to be more reduced by the expression of an aggregation‐prone polyglutamine protein in HSF1‐knockdown cells \[[43](#feb412863-bib-0043){ref-type="ref"}\]. Here, we showed that mitochondrial membrane potential or relative OCR were more reduced in HSF1‐knockdown cells than those in scrambled RNA‐treated cells during treatment with GTPP, CDDO, or rotenone (Fig. [5](#feb412863-fig-0005){ref-type="fig"}). Our observations suggested that mitochondrial function in conditions of impaired mitochondrial proteostasis is maintained in part by the HSF1‐dependent upregulation of mitochondrial chaperone genes.

It is worth noting that *HSP60* and *HSP10* uniquely share a bidirectional promoter containing an HSE, which consisted of at least four inverted repeats of an exceptionally conserved consensus nGAAn unit \[[16](#feb412863-bib-0016){ref-type="ref"}, [17](#feb412863-bib-0017){ref-type="ref"}\]. ChIP‐seq and ChIP‐qPCR data analysis showed that HSF1 constitutively binds to the bidirectional promoter at a much higher level than to the promoters of other *HSP* genes including *HSP70* in MEF cells, and the level of HSF1 binding to this promoter was dramatically elevated during heat shock \[[18](#feb412863-bib-0018){ref-type="ref"}, [19](#feb412863-bib-0019){ref-type="ref"}\]. HSF1 was mostly converted to a DNA‐binding trimer during heat shock, whereas a small part of HSF1 shifted to a trimer during the UPR^mt^ (Fig. [3C](#feb412863-fig-0003){ref-type="fig"}). Unexpectedly, *in vivo* HSF1 binding to the bidirectional promoter was induced in cells treated with GTPP and CDDO at the same levels as that in cells treated with heat shock (Fig. [4](#feb412863-fig-0004){ref-type="fig"}), although level of HSF1 binding to this promoter was little elevated in cells treated with rotenone. Thus, analysis of *in vivo* HSF1 binding to the unique bidirectional promoter of *HSP60/HSP10* could be a sensitive marker of the UPR^mt^.
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